236 related articles for article (PubMed ID: 31593240)
21. Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors.
Buas MF; Gu H; Djukovic D; Zhu J; Drescher CW; Urban N; Raftery D; Li CI
Gynecol Oncol; 2016 Jan; 140(1):138-44. PubMed ID: 26521694
[TBL] [Abstract][Full Text] [Related]
22. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.
Lee AW; Ness RB; Roman LD; Terry KL; Schildkraut JM; Chang-Claude J; Doherty JA; Menon U; Cramer DW; Gayther SA; Risch H; Gentry-Maharaj A; Goodman MT; Modugno F; Eilber U; Moysich KB; Berchuck A; Rossing MA; Jensen A; Wicklund KG; Cushing-Haugen KL; Hogdall E; Rudolph A; Thompson PJ; Wilkens LR; Kjaer SK; Carney ME; Stram DO; Ramus SJ; Wu AH; Pike MC; Pearce CL;
Obstet Gynecol; 2016 May; 127(5):828-836. PubMed ID: 27054934
[TBL] [Abstract][Full Text] [Related]
23. Fast transmission of alterations in plasma phosphatidylcholine/sphingomyelin ratio and lyso phosphatidylcholine levels into changes of red blood cell membrane phospholipid composition after low density lipoprotein apheresis.
Kulschar R; Engelmann B; Bräutigam C; Duhm J; Thiery J; Richter WO
Eur J Clin Invest; 1995 Apr; 25(4):258-65. PubMed ID: 7601201
[TBL] [Abstract][Full Text] [Related]
24. Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Harewood R; Rothwell JA; Bešević J; Viallon V; Achaintre D; Gicquiau A; Rinaldi S; Wedekind R; Prehn C; Adamski J; Schmidt JA; Jacobs I; Tjønneland A; Olsen A; Severi G; Kaaks R; Katzke V; Schulze MB; Prada M; Masala G; Agnoli C; Panico S; Sacerdote C; Jakszyn PG; Sánchez MJ; Castilla J; Chirlaque MD; Atxega AA; van Guelpen B; Heath AK; Papier K; Tong TYN; Summers SA; Playdon M; Cross AJ; Keski-Rahkonen P; Chajès V; Murphy N; Gunter MJ
EBioMedicine; 2024 Mar; 101():105024. PubMed ID: 38412638
[TBL] [Abstract][Full Text] [Related]
25. Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.
Röhnisch HE; Kyrø C; Olsen A; Thysell E; Hallmans G; Moazzami AA
BMC Med; 2020 Jul; 18(1):187. PubMed ID: 32698845
[TBL] [Abstract][Full Text] [Related]
26. Prepregnancy Body Mass Index and Lipoprotein Fractions are Associated with Changes in Women's Serum Metabolome from Late Pregnancy to the First Months of Postpartum.
Padilha M; Ferreira ALL; Normando P; Freire SDSR; Fiamoncini J; Brennan L; Yin X; Kac G
J Nutr; 2023 Jan; 153(1):56-65. PubMed ID: 36913479
[TBL] [Abstract][Full Text] [Related]
27. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients.
Aslan M; Kıraç E; Kaya S; Özcan F; Salim O; Küpesiz OA
Lipids; 2018 Mar; 53(3):313-322. PubMed ID: 29663386
[TBL] [Abstract][Full Text] [Related]
28. Specific, rapid, and sensitive enzymatic measurement of sphingomyelin, phosphatidylcholine and lysophosphatidylcholine in serum and lipid extracts.
Hidaka H; Yamauchi K; Ohta H; Akamatsu T; Honda T; Katsuyama T
Clin Biochem; 2008 Oct; 41(14-15):1211-7. PubMed ID: 18619432
[TBL] [Abstract][Full Text] [Related]
29. Milk polar lipids favorably alter circulating and intestinal ceramide and sphingomyelin species in postmenopausal women.
Le Barz M; Vors C; Combe E; Joumard-Cubizolles L; Lecomte M; Joffre F; Trauchessec M; Pesenti S; Loizon E; Breyton AE; Meugnier E; Bertrand K; Drai J; Robert C; Durand A; Cuerq C; Gaborit P; Leconte N; Bernalier-Donadille A; Cotte E; Laville M; Lambert-Porcheron S; Ouchchane L; Vidal H; Malpuech-Brugère C; Cheillan D; Michalski MC
JCI Insight; 2021 May; 6(10):. PubMed ID: 33857018
[TBL] [Abstract][Full Text] [Related]
30. Early postoperative changes of sphingomyelins and ceramides after laparoscopic sleeve gastrectomy.
Özer H; Aslan İ; Oruç MT; Çöpelci Y; Afşar E; Kaya S; Aslan M
Lipids Health Dis; 2018 Nov; 17(1):269. PubMed ID: 30474555
[TBL] [Abstract][Full Text] [Related]
31. Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health Study.
Fretts AM; Jensen PN; Hoofnagle AN; McKnight B; Sitlani CM; Siscovick DS; King IB; Psaty BM; Sotoodehnia N; Lemaitre RN
Clin Chem; 2021 Nov; 67(12):1650-1659. PubMed ID: 34580702
[TBL] [Abstract][Full Text] [Related]
32. Anti-Mullerian hormone and risk of invasive serous ovarian cancer.
Schock H; Lundin E; Vääräsmäki M; Grankvist K; Fry A; Dorgan JF; Pukkala E; Lehtinen M; Surcel HM; Lukanova A
Cancer Causes Control; 2014 May; 25(5):583-9. PubMed ID: 24562905
[TBL] [Abstract][Full Text] [Related]
33. Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition.
Breeur M; Ferrari P; Dossus L; Jenab M; Johansson M; Rinaldi S; Travis RC; His M; Key TJ; Schmidt JA; Overvad K; Tjønneland A; Kyrø C; Rothwell JA; Laouali N; Severi G; Kaaks R; Katzke V; Schulze MB; Eichelmann F; Palli D; Grioni S; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Olsen KS; Sandanger TM; Nøst TH; Quirós JR; Bonet C; Barranco MR; Chirlaque MD; Ardanaz E; Sandsveden M; Manjer J; Vidman L; Rentoft M; Muller D; Tsilidis K; Heath AK; Keun H; Adamski J; Keski-Rahkonen P; Scalbert A; Gunter MJ; Viallon V
BMC Med; 2022 Oct; 20(1):351. PubMed ID: 36258205
[TBL] [Abstract][Full Text] [Related]
34. The utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosis.
Kadija S; Stefanovic A; Jeremic K; Radojevic MM; Nikolic L; Markovic I; Atanackovic J
Int J Gynecol Cancer; 2012 Feb; 22(2):238-44. PubMed ID: 22214964
[TBL] [Abstract][Full Text] [Related]
35. Altered Plasma Amino Acids and Lipids Associated With Abnormal Glucose Metabolism and Insulin Resistance in Older Adults.
Semba RD; Gonzalez-Freire M; Moaddel R; Sun K; Fabbri E; Zhang P; Carlson OD; Khadeer M; Chia CW; Salem N; Ferrucci L
J Clin Endocrinol Metab; 2018 Sep; 103(9):3331-3339. PubMed ID: 29947780
[TBL] [Abstract][Full Text] [Related]
36. Serum lipidome screening in patients with stage I non-small cell lung cancer.
Klupczynska A; Plewa S; Kasprzyk M; Dyszkiewicz W; Kokot ZJ; Matysiak J
Clin Exp Med; 2019 Nov; 19(4):505-513. PubMed ID: 31264112
[TBL] [Abstract][Full Text] [Related]
37. Oviductal glycoprotein (OVGP1, MUC9): a differentiation-based mucin present in serum of women with ovarian cancer.
Maines-Bandiera S; Woo MM; Borugian M; Molday LL; Hii T; Gilks B; Leung PC; Molday RS; Auersperg N
Int J Gynecol Cancer; 2010 Jan; 20(1):16-22. PubMed ID: 20130498
[TBL] [Abstract][Full Text] [Related]
38. Lipidomics and pancreatic cancer risk in two prospective studies.
Naudin S; Sampson JN; Moore SC; Albanes D; Freedman ND; Weinstein SJ; Stolzenberg-Solomon R
Eur J Epidemiol; 2023 Jul; 38(7):783-793. PubMed ID: 37169992
[TBL] [Abstract][Full Text] [Related]
39. Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition.
Ose J; Fortner RT; Rinaldi S; Schock H; Overvad K; Tjonneland A; Hansen L; Dossus L; Fournier A; Baglietto L; Romieu I; Kuhn E; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Masala G; Sieri S; Tumino R; Sacerdote C; Mattiello A; Ramon Quiros J; Obón-Santacana M; Larrañaga N; Chirlaque MD; Sánchez MJ; Barricarte A; Peeters PH; Bueno-de-Mesquita HB; Onland-Moret NC; Brändstedt J; Lundin E; Idahl A; Weiderpass E; Gram IT; Lund E; Kaw KT; Travis RC; Merritt MA; Gunther MJ; Riboli E; Kaaks R
Int J Cancer; 2015 Jan; 136(2):399-410. PubMed ID: 24890047
[TBL] [Abstract][Full Text] [Related]
40. Serum lipids profiling perturbances in patients with ischemic heart disease and ischemic cardiomyopathy.
Yang L; Wang L; Deng Y; Sun L; Lou B; Yuan Z; Wu Y; Zhou B; Liu J; She J
Lipids Health Dis; 2020 May; 19(1):89. PubMed ID: 32386519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
